custom image

Joint meeting with Plant Genome Engineering: From Lab to Field

Precision Engineering of the Genome, Epigenome and Transcriptome

March 8-10, 2021 | 10:00AM EST | 3:00PM UTC | 4:00PM CET*
*Program is in development and subject to change


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.

 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries

Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.

Apply Here

Over the last several years, new genome engineering tools have revolutionized the ability to interrogate biological systems, engineer innovative biotechnologies, and model and treat human disease. The genome engineering field continues to evolve at a frenzied pace, including both the development of new fundamental tools and their application to addressing societal needs. This Keystone Symposium will cover this spectrum of advances, including the most recent technological innovations in genome, epigenome, and transcriptome precision engineering. The conference will also highlight recent advances in developing human therapeutics with these tools, including emerging clinical trial results and preclinical examples of novel modes of intervention. The Symposium will include a variety of topics of interest to the broad research community, including next-generation applications such as high-throughput screening, synthetic biology, and chromatin and RNA imaging and diagnostics. Finally, the Symposium will conclude with examples of how emerging technologies can be integrated for an unprecedented level of resolution of cellular processes – such as genome engineering combined with single-cell analysis methods. Collectively, this meeting will build on its history of success by familiarizing the audience with the latest advances in tool development, providing an update on clinical application of these tools, and generating an appreciation for the breadth of scientific areas impacted by the Genome Engineering Revolution.

Apply Here for Free On Demand Access


Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD


Abstract Submission:
‣ For Short Talk Consideration: Passed
‣ For Poster Booth: Passed
ePoster / SciTalk Submission: Passed
Financial Aid Application: Passed

*Abstract submission is required in order to submit an ePoster and/or Scitalk


Program Details

Speaking at this eSymposia

Britt S. Adamson

Princeton University, USA

Aravind Asokan

Duke University, USA

Chiara Bonini

Ospedale San Raffaele, Italy

Jacob E. Corn

ETH Zürich, Switzerland

Cecilia Cotta-Ramusino

Tessera Therapeutics, USA

James Dahlman

Georgia Tech / Emory Medical School, USA

John G. Doench

Broad Institute of MIT and Harvard University, USA

Nicole Gaudelli

Beam Therapeutics, USA

Charles Gersbach

Duke University, USA

Rachel E. Haurwitz

Caribou Biosciences Inc., USA

Patrick D. Hsu

University of California, Berkeley, USA

Ahmad S. Khalil

Boston University, USA

Hyongbum Henry Kim

Yonsei University College of Medicine, South Korea

Prashant Mali

University of California, San Diego, USA

Ana Moreno Collado

Navega Therapeutics, USA

David G. Ousterout

Locus Biosciences, Inc., USA

Jennifer E. Phillips-Cremins

University of Pennsylvania, USA

Matthew Porteus

Stanford University School of Medicine, USA

Daniel J. Siegwart

University of Texas Southwestern Medical Center, USA

Samuel H. Sternberg

Columbia University, USA

Fyodor D. Urnov

University of California, Berkeley, USA

Bas van Steensel

Netherlands Cancer Institute, Netherlands

Jonathan S. Weissman

Whitehead Institute and MIT, USA

Tim W. Yu

Boston Children's Hospital, USA


This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.

The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.

Related Keystone Symposia In-Person Meetings

Explore all cancer-related meetings on the Keystone Symposia website.

custom image

custom image

custom image

Donate to Keystone Symposia

custom image